Advances and Hurdles of PLGA-Based Therapy for Pancreatic Cancer
Pancreatic cancer (PC) is one of the most aggressive malignancies, with a very low 5-year survival rate due to late diagnosis, rapid metastasis, and resistance to conventional therapies. The pancreas’s deep anatomical location complicates early detection, and most patients present with advanced or metastatic disease, l...